Matrix Partners and FreesFund Invest ~USD6m in Angel Round for China’s ChainGen Bio
Source(s): 36Kr
Matrix Partners and FreesFund invested ~USD6m in an angel round for ChainGen Bio, a China-based antibody-drug conjugates (ADCs) developer. Read more
Source(s): 36Kr
Matrix Partners and FreesFund invested ~USD6m in an angel round for ChainGen Bio, a China-based antibody-drug conjugates (ADCs) developer. Read more